These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6688258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW, Hollis BW, Bell NH, Epstein S.
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
    Unakami H, Furukawa Y, Sohn HE, Yumita S, Miura R, Hanew K, Yoshinaga K.
    Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Deficient prolactin response to parathyroid hormone in hypocalcemic and normocalcemic pseudohypoparathyroidism.
    Kruse K, Gutekunst B, Kracht U, Schwerda K.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1099-105. PubMed ID: 6262363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
    Yasuda T, Nakajima H.
    Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
    [Abstract] [Full Text] [Related]

  • 13. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L, Aarskog D.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [Abstract] [Full Text] [Related]

  • 14. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib.
    Silve C, Santora A, Breslau N, Moses A, Spiegel A.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):640-4. PubMed ID: 3005354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiple pre- and postreceptor defects in pseudohypoparathyroidism (a multicenter study with twenty four patients).
    Radeke HH, Auf'mkolk B, Jüppner H, Krohn HP, Keck E, Hesch RD.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):393-402. PubMed ID: 3001127
    [Abstract] [Full Text] [Related]

  • 18. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR, Perlmutter S, Aloia JF.
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.